Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 11 (5-6), 299-305
- https://doi.org/10.1016/0166-3542(89)90039-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus.The Journal of Experimental Medicine, 1989
- Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1988
- Replication of human immunodeficiency virus: yield of infectious virus under single growth cycle conditionsArchiv für die gesamte Virusforschung, 1988
- Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: Receptor modulation and differentiation induced by phorbol esterVirology, 1987
- Ribavirin Antagonizes the Effect of Azidothymidine on HIV ReplicationScience, 1987
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985
- Trans -Acting Transcriptional Activation of the Long Terminal Repeat of Human T Lymphotropic Viruses in Infected CellsScience, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984